Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response from PTSC IR on Shareholders meeting
Personally, I don't want an SHM until say July or August of 2013. I want to know the comprehensive plan after the major hurdles will be lept at the NDoC and ITC. If we lose in those venues then who cares? If we win then one would expect a well organized SHM. If we win and substantial money is made, I would suggest the company start a hedge fund or buy 100s of McDs and get into an easier profession than tech development and IP licensing. Somehing much more tangible with proven business and operational plans. I'll probably be gone long before such a plan would be announced, but that is what they should do ...
Share
New Message
Please login to post a reply